NFKB1 and myositis disease: An accurate understanding of the mechanisms of action of NF-κB in the pathogenesis of myositis and related diseases will be the first step in developing new therapies based not only on acute treatment but also on causal treatment before irreversible damage and changes in the form of infiltrates occur.